Results 51 to 60 of about 13,266 (251)
S1‐Leitlinie: Therapie der generalisierten pustulösen Psoriasis
Zusammenfassung Die S1‐Leitlinie „Therapie der generalisierten pustulösen Psoriasis (GPP)“ ist eine deutsche Leitlinie, die nach den Kriterien der AWMF erstellt wurde. In der Langfassung werden Aspekte wie klinisches Bild, Pathogenese, Diagnose und Differenzialdiagnose, Begleiterkrankungen und Therapien beleuchtet.
Rotraut Mößner +17 more
wiley +1 more source
S1 Guideline: Therapy of generalized pustular psoriasis
Summary The S1 guideline “Therapy of generalized pustular psoriasis (GPP)” is a German guideline developed in accordance with the criteria of the AWMF. The full version addresses clinical presentation, pathogenesis, diagnosis and differential diagnosis, comorbidities, and therapy.
Rotraut Mößner +17 more
wiley +1 more source
PUVA Induced Bullous Pemphigoid in a Patient with Mycosis Fungoides
Background. Bullous pemphigoid is an autoimmune subepidermal blistering skin disease in which autoantibodies are directed against components of the basement membrane.
Birgül Özkesici +5 more
doaj +1 more source
ABSTRACT Topical bexarotene 1% gel is an approved skin‐directed treatment for refractory or persistent stage IA‐IB cutaneous T‐cell lymphoma, but real‐world evidence in mycosis fungoides (MF), particularly regarding maintenance use after complete response, remains limited.
Fatich Memet +6 more
wiley +1 more source
Einfluss von Psoralen und UVA (PUVA) auf den Zellteilungszyklus von humanen Keratinozyten [PDF]
Für den antiproliferativen Effekt der Kombinationstherapie aus UVA-Strahlung mit dem Furocoumarin Psoralen (PUVA) wird die Ausbildung von Doppelstrangvernetzungen (Interstrand Cross Links, ICL) verantwortlich gemacht.
Joerges, Christoph
core +1 more source
A comprehensive retrospective analysis of 121 immune checkpoint inhibitor‐induced eosinophilic fasciitis cases, including clinical presentation, diagnostic features and treatment outcomes using data from the EADV Task Force ‘Dermatology for Cancer Patients’, two international pharmacovigilance databases and the current literature.
Tristan V. M. Bruijn +17 more
wiley +1 more source
ABSTRACT Background Scleromyxedema (SMX) is a cutaneous mucinosis characterised by an abnormal accumulation of mucin in the skin and limited treatment options. Assessment of therapy response during treatment is challenging. Objectives Patients with SMX receiving high‐dose intravenous IVIg therapy were included to assess validity of the double modified ...
Julia K. Winkler, Alexander H. Enk
wiley +1 more source
Noncutaneous Malignant Tumors in the PUVA Follow-up Study: 1975–1996
There is concern about possible association between PUVA treatment and an increased risk of noncutaneous cancer. An alteration in the risk of cancer among persons with psoriasis has also been postulated. To test this hypothesis, for nearly two decades we
Väkevä, Liisa H. +2 more
core +1 more source
COMPARACIÓN DE CALCITRIOL MAS PUVA CON RESPECTO A LA MONOTERAPIA CON PUVA EN PACIENTES CON PSORIASIS
Se estudiaron 32 pacientes con psoriasis en placas que asistieron a la consulta de dermatología del CES en Medellín, Colombia, en el 2003, remitidos para tratamiento con psoralenos – UVA (PUVA).
Jimenez, Sol Beatriz +4 more
core +1 more source
Photoprotective practices in patients with mycosis fungoides: a questionnaire‐based survey study
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Ioannis‐Alexios Koumprentziotis +6 more
wiley +1 more source

